发明人王建平,郭海燕,沈红梅. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 112191508 A, 授权公告日 2018-07-04.
发明人郑宇鹏,唐晓军,陈志强. "Method for the Synthesis of 3-Pentyl-2-((1E,3Z)-3-(3-pentylbenzo[d]thiazol-2(3H)-ylidene)prop-1-en-1-yl)benzo[d]thiazol-3-ium iodide" [P]. 中国发明专利, 专利号 CN 117037157 A, 授权公告日 2020-02-12.
发明人林芳,张德明,唐晓军. "A Process for Preparing High-Purity 3-Pentyl-2-((1E,3Z)-3-(3-pentylbenzo[d]thiazol-2(3H)-ylidene)prop-1-en-1-yl)benzo[d]thiazol-3-ium iodide" [P]. 中国发明专利, 专利号 CN 114646671 A, 授权公告日 2025-06-14.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2024, 171, 69-73.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2017, 995, 4509-4526.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 3-Pentyl-2-((1E,3Z)-3-(3-pentylbenzo[d]thiazol-2(3H)-ylidene)prop-1-en-1-yl)benzo[d]thiazol-3-ium iodide Using HRMS and NMR". Chromatographia, 2017, 776, 2461-2464.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2018, 498, 695-709.